ORPHACOL

This brand name is authorized in Austria, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Poland, United Kingdom

Active ingredients

The drug ORPHACOL contains one active pharmaceutical ingredient (API):

1 Cholic acid
UNII G1JO7801AE - CHOLIC ACID

Cholic acid is the predominant primary bile acid in man. In patients with inborn deficiency of 3β-Hydroxy-Δ5−C27-steroid oxidoreductase and Δ4-3-Oxosteroid-5β-reductase, the biosynthesis of primary bile acids is reduced or absent. The rational basis for treatment consists of restoration of the bile aciddependent component of bile flow enabling restoration of biliary secretion and biliary elimination of toxic metabolites; inhibition of the production of the toxic bile acid metabolites by negative feedback on cholesterol 7α-hydroxylase, which is the rate-limiting enzyme in bile acid synthesis; and improvement of the patient’s nutritional status by correcting intestinal malabsorption of fats and fat-soluble vitamins.

Read about Cholic acid

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ORPHACOL Hard capsule European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A05AA03 A Alimentary tract and metabolism → A05 Bile and liver therapy → A05A Bile therapy → A05AA Bile acid preparations
Discover more medicines within A05AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1624935, 1624946, 1624957, 1624968, 1624979, 1624980
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 113870001, 113870004
Country: FR Base de données publique des médicaments Identifier(s): 62882708, 63316225
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 290082, 290086
Country: IT Agenzia del Farmaco Identifier(s): 043028012, 043028024, 043028036, 043028048, 043028051, 043028063
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1071217, 1071218, 1071219, 1071220, 1071221, 1071222
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100312860, 100312877

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.